ID: ALA1277321

Max Phase: Preclinical

Molecular Formula: C15H20FN3O4S

Molecular Weight: 357.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1O[C@@H](NC(=S)N/N=C/c2ccc(F)cc2)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C15H20FN3O4S/c1-2-10-11(20)12(21)13(22)14(23-10)18-15(24)19-17-7-8-3-5-9(16)6-4-8/h3-7,10-14,20-22H,2H2,1H3,(H2,18,19,24)/b17-7+/t10-,11-,12+,13-,14-/m1/s1

Standard InChI Key:  LHWNEDABKKCTIO-XUYIYWCOSA-N

Associated Targets(Human)

Muscle glycogen phosphorylase 197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glycogen phosphorylase, muscle form 1331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 357.41Molecular Weight (Monoisotopic): 357.1159AlogP: -0.16#Rotatable Bonds: 4
Polar Surface Area: 106.34Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.78CX Basic pKa: 2.02CX LogP: 1.19CX LogD: 1.19
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.29Np Likeness Score: -0.58

References

1. Alexacou KM, Tenchiu Deleanu AC, Chrysina ED, Charavgi MD, Kostas ID, Zographos SE, Oikonomakos NG, Leonidas DD..  (2010)  The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.,  18  (22): [PMID:20947361] [10.1016/j.bmc.2010.09.039]

Source